Skip to content

Key resources

  • Bibliography
    Bibliography
  • Health promotion
    Health promotion
  • Health practice
    Health practice
  • Yarning places
    Yarning places
  • Programs
    Programs
  • Organisations
    Organisations
  • Conferences
    Conferences
  • Courses
    Courses
  • Funding
    Funding
  • Jobs
    Jobs
Australian Indigenous HealthBulletin
 
  • Home
    • » Key resources and services
      • » Programs and projects
        • » Immunogenicity, carriage and otitis media outcomes of pneumococcal conjugate vaccines PHiD-CV and 13PCV in sequence or alone in high-risk Indigenous infants: a randomised controlled trial

Immunogenicity, carriage and otitis media outcomes of pneumococcal conjugate vaccines PHiD-CV and 13PCV in sequence or alone in high-risk Indigenous infants: a randomised controlled trial

 

Overview

This randomised control trial aims to determine whether early commencement of a sequential schedule of two pneumococcal conjugate vaccines, Pneumococcal Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV or Synflorix) and 13-valent pneumococcal conjugate vaccine (PCV13 or Prevenar13), given in sequence at one, two, four (PHiD-CV), and 6 months (PCV13), gives greater protection against otitis media compared to either PCV13-alone or PHiD-CV-alone at two, four, and six months.

The project also aims to determine if a combination of pneumococcal vaccines is superior to single vaccines in terms of immunogenicity, nasopharyngeal carriage of otitis media pathogens, and all-cause otitis media in Indigenous infants living in remote communities.

The project is funded by the National Health and Medical Research Council (NHMRC), and is headed by Menzies School of Health Research.

Contacts

Associate Professor Amanda Leach
Chief Investigator
Menzies School of Health Research
John Mathews Building
Royal Darwin Hospital Campus
Rocklands Drive
Casuarina NT 0810
PO Box 41096
Casuarina NT 0811
Email: amanda.leach@menzies.edu.au

Links

 
Last updated: 22 June 2015
 
Return to top